Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
11,898 total articles
Korro Bio, Inc. (NASDAQ:KRRO) COO Todd Chappell executed a mandatory sale of 3,168 shares on June 16, 2026, totaling $34,309. The transaction, driven by tax withholding obligations from vesting restricted stock units, reduced his direct holdings to 16,966 shares. This insider activity occurs as the biotech company navigates significant pipeline dev…
Colin R. Sabol, a director at Energy Recovery, Inc. (NASDAQ:ERII), executed a $99,267 purchase of 11,180 common shares on June 15, 2026, bringing his direct holdings to 55,671 shares. The transaction occurs as the company navigates a leadership transition, with Alex Buehler appointed as interim president and CEO, following David Moon's accelerated …
Jocelyn Moore, a director at OppFi Inc. (NASDAQ:OPFI), executed a sale of 39,076 shares of the company's Class A Common Stock on June 15, 2026. The transaction, valued at $324,936, follows the company's reported first-quarter 2026 earnings that surpassed analyst expectations. This insider activity provides a snapshot of executive share movement aga…
Paul A. Uhlman, Vice President at Federated Hermes, Inc. (NYSE:FHI), executed a strategic divestment of 6,145 shares of Class B Common Stock on June 16, 2026. The transaction, valued at $360,524, was structured to satisfy tax liabilities stemming from restricted stock vesting. This move occurs against a backdrop of robust stock performance, with FH…
Lifevantage Corp (NASDAQ: LFVN) Director Darwin Lewis has increased his direct stake in the company by purchasing 705 shares valued at $6,059. This transaction, filed with the SEC on June 15, 2026, occurs against a backdrop of recent financial reporting and market activity that highlights both challenges and investor sentiment surrounding the firm.
John Cox, the CEO and President of Dyne Therapeutics, Inc. (NASDAQ:DYN), recently sold 2,683 shares of the company's common stock on June 16, 2026, for a total value of $49,179. The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units granted to Mr. Cox on December 4, 2024. This transaction was a…
Horizon Kinetics Asset Management LLC, the investment adviser and 10% shareholder of RENN Fund, Inc. (NASDAQ:RCG), has expanded its direct ownership in the fund. The firm acquired 756 shares valued at $2,071 on June 16, 2026, bringing its total holding to 921,324 shares. The transaction was filed with the Securities and Exchange Commission the foll…
Credit Acceptance Corp (NASDAQ:CACC) Chief Legal Officer Erin J. Kerber executed a series of stock sales totaling approximately $32,292 over a three-day period in mid-June 2026. The transactions occurred while the company's stock traded near its 52-week high, reflecting a period of strong performance for the lender. Concurrently, Kerber exercised s…
Ralph J. Lober II, serving as both CEO and President of Consumers Bancorp Inc. (NASDAQ:CBKM), executed a purchase of 500 common shares on June 17, 2026. The transaction was finalized at a per-share price of $29.25, resulting in a total capital outlay of $14,625. This acquisition occurs as the equity trades in close proximity to its 52-week peak of …
Luis Alberto Fallo, a director at GAS TRANSPORTER OF THE SOUTH INC (NASDAQ:TGS), executed a direct share acquisition on June 9, 2026, purchasing 4,680 American Depositary Shares (ADSs) representing Class B equity through AURA INTERVEST LTD. The transaction, valued at $136,914 based on a per-share price of $29.2553, increases Fallo’s indirect holdin…
Brian Shirley, a director at Advanced Energy Industries Inc. (NASDAQ: AEIS), executed a sale of 1,234 shares on June 15, 2026, totaling $459,479 at $372.35 per share. The transaction followed a Rule 10b5-1 plan adopted in December 2025 and reduced his direct holdings to 6,663 shares. This activity occurs amid a significant stock price appreciation …
Robin Mink, Executive Vice President and Chief Talent Management Officer at CNB Financial Corp/PA (NASDAQ:CCNE), executed a transaction resulting in the sale of 103.568 shares of company common stock. The transaction, valued at $3,161, was completed on June 4, 2026, according to a recent SEC Form 4 filing. The shares were sold from an indirect hold…
Texas Pacific Land Corp (NASDAQ:TPL) director Peter Doyle acquired 4 shares of common stock on June 15, 2026, through an automatic investment plan tied to the company's dividend reinvestment program. The transaction, valued at $1,527, brings his direct shareholding to 146,936 shares, excluding charitable holdings. This purchase follows Texas Pacifi…
Jon R. Marinelli, a director at United States Antimony Corp (NASDAQ: UAMY), executed a purchase of the company's common stock on June 15, 2026. The transaction involved the acquisition of 12,500 shares at a weighted average price of $7.45 per share, bringing his total direct holdings to 12,500 shares. This insider activity unfolds against a backdro…
Saba Capital Management, L.P., a significant 10% shareholder in the BlackRock ESG Capital Allocation Term Trust (ECAT), executed a strategic reduction of its holdings through the sale of 118,920 common shares. The transaction, finalized over two trading days in mid-June 2026, netted approximately $1.84 million in proceeds. Despite the reduction, Sa…
Angela C. Drake, Vice President and Chief Financial Officer at Toro Co (TTC), executed a direct purchase of 160 shares of the company’s common stock on June 16, 2026, according to a recent Securities and Exchange Commission (SEC) filing. The transaction, valued at approximately $14,400, was completed at a per-share price of $90.005. This acquisitio…
Nicholas W. Zillges, President and Chief Executive Officer of Marathon Bancorp, Inc., executed a direct equity acquisition on June 16, 2026, purchasing 970 shares of the company's common stock at a unit price of $15.00, totaling $14,550. Following this transaction, Mr. Zillges' direct common stock holdings stand at 57,205 shares. This acquisition o…
Brian Archbold, Senior Vice President of Operations at Mesa Laboratories Inc. (NASDAQ: MLAB), executed a significant transaction involving the disposal of company equity on June 16, 2026. This sale occurs against a backdrop of shifting corporate leadership and recent financial performance metrics. The insider activity coincides with broader market …
Mesa Laboratories Inc. (NASDAQ:MLAB) Chief Accounting Officer Lyndsey Crennen sold 118 shares on June 16, 2026, generating $11,949 from the transaction. The sale was executed to cover taxes on Restricted Stock Units (RSUs) that vested on June 15, 2026. Following the transaction, Crennen directly holds 1,473 shares of the company's common stock. The…
Jill Bourland, a director at Isabella Bank Corp (NASDAQ: ISBA), executed a purchase of 7.2411 shares of the company's common stock on June 16, 2026. The transaction, valued at $299, brings her direct ownership to 5,876.8485 shares. This insider activity coincides with broader corporate developments, including the approved $54.6 million acquisition …
George Herrera, a director at Travel & Leisure Co. (TNL), executed a sale of 500 shares of the company's common stock on June 16, 2026. The transaction, valued at $37,580, occurred at a share price of $75.16. This insider activity follows a significant 59% surge in TNL's stock price over the past year, with the stock currently trading at $77.11. Th…
Mesa Laboratories Inc. CFO John Sakys sold 1,223 shares on June 16, 2026, at $101.267 per share to cover tax liabilities from restricted stock unit vesting. The transaction occurs against a backdrop of recent quarterly revenue misses, a 32% drop in the Biological Products Division, and an upcoming CEO departure. Jefferies has raised its price targe…
David C Chang, a director at AXT Inc. (NASDAQ: AXTI), executed a significant transaction on June 15, 2026, selling 8,333 shares of common stock. The sale, valued at approximately $926,392, occurred at a price of $111.1715 per share. This divestment follows a period of substantial market appreciation for AXT Inc., which has delivered a 4,671% return…
Jesse Chen, a director at AXT Inc. (NASDAQ: AXTI), executed a significant sale of company stock on June 15, 2026. The transaction involved 6,172 shares, bringing the total value to approximately $711,284. This sale occurs against a backdrop of recent financial performance and valuation metrics that suggest the stock may be trading at a premium rela…
Anixa Biosciences (NASDAQ: ANIX) director Lewis H. Titterton Jr. recently executed a direct purchase of the company's common stock, according to a filing with the Securities and Exchange Commission. The transaction, completed on June 16, 2026, involved the acquisition of 2,836 shares at a price of $2.64 per share, bringing the total value to $7,487…
